-
-
-
-
-
-
-
Needham Downgrades Day One Biopharmaceuticals (DAWN) to Hold
-
-
-
-
-
-
-
Day One Biopharmaceuticals (DAWN) PT Lowered to $22 at H.C. Wainwright
-
-
-
-
-
-
-
Increasing unusual option volume: HNRG FOXA CWAN RSI PLCE VIPS LW DAWN
-
-
-
-
-
-
-
Piper Sandler Starts Day One Biopharmaceuticals (DAWN) at Overweight
-
-
-
-
-
-
-
Day One Biopharmaceuticals (DAWN) Reports Preliminary 2024 OJEMDA Net Product Revenue and Highlights 2025 Corporate Priorities
-
-
-
-
-
-
-
Day One Biopharmaceuticals (DAWN) Announces 10.55M Share Offering at $14.50/sh
-
417,487 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

